Abstract
Small cell lung cancer (SCLC), which originated from neuroendocrine tissue, can develop into paraneoplastic endocrine syndromes, such as Cushing syndrome, because of an inappropriate secretion of ectopic adrenocorticotropic hormone (ACTH). This paraneoplastic syndrome is known to be a poor prognostic factor in SCLC. The reason for poor survival may be because of a higher risk of infection associated with hypercortisolemia. Therefore, early detection and appropriate treatment for this syndrome is necessary. But the diagnosis is challenging and the source of ACTH production can be difficult to identify. We report a 69-year-old male patient who had severe hypokalemia, metabolic alkalosis, and hypertension as manifestations of an ACTH-secreting small cell carcinoma of the lung. He was treated with ketoconazole and spironolactone to control the ACTH dependent Cushing syndrome. He survived for 15 months after chemotherapy, which is unusual considering the poor outcome of the ectopic ATH syndrome associated with SCLC.
| Original language | English |
|---|---|
| Pages (from-to) | 436-439 |
| Number of pages | 4 |
| Journal | Tuberculosis and Respiratory Diseases |
| Volume | 78 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Oct 2015 |
Bibliographical note
Publisher Copyright:© Copyright 2015 The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ACTH syndrome
- Ectopic
- Paraneoplastic syndromes
- Small cell lung carcinoma
Fingerprint
Dive into the research topics of 'A case of ectopic adrenocorticotropic hormone syndrome in small cell lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver